The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Despite intensified efforts to increase HIV testing in sub-Saharan Africa, poorer and less educated people are still missing out.
Long-acting, injectable cabotegravir is as effective as daily PrEP pills at preventing HIV among cisgender men and transgender women who have sex with men.
When starting treatment in the third trimester, women taking dolutegravir more likely to achieve undetectable viral loads at the time of giving birth compared with those taking efavirenz.
Study finds a programme in Côte d’Ivoire offering male-only groups and peer support is helping men test for HIV, accept treatment and stay on it.
HIV drug resistance among treatment-naïve people in China rising rapidly from 2012 and tops 10% in Central China.